Fortress Biotech Inc (NASDAQ:FBIO) shares are trading lower by 18.5% to $1.49 Friday afternoon after the company announced the pricing of a $8 million registered direct offering and concurrent private ...

Fortress Biotech is trading below its cash balance, offering deep value relative to its assets and financial improvements.

The financial regulations require hedge funds and wealthy investors that exceeded the $100 million equity holdings threshold to file a report that shows their positions at the end of every quarter.

Momentum investors typically don't time the market or "buy low and sell high." In other words, they avoid betting on cheap stocks and waiting long for them to recover. Instead, they believe that ...

Momentum investors typically don't time the market or "buy low and sell high." In other words, they avoid betting on cheap stocks and waiting long for them to recover. Instead, they believe that ...

Fortress Biotech, Inc. FBIO was a big mover last session, as the company saw its shares rise more than 6% on the day. The move came on solid volume too with far more shares changing hands than in a ...

The unit is selling the voucher for $205 million, the company said. 20% of the proceeds from the voucher sale is owed to the Eunice Kennedy Shriver National Institute of Child Health and Human ...